Label-free Array Systems Market Size Estimated at US$ 2.4 Bn by 2031, TMR Study

Usability of label-free technologies to generate biorelevant data, for efficient drug development and precision medicine underscores growth

Wilmington, Delaware, United States, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - A detailed analysis of label-free array systems market pinpoints, significance of label-free detection techniques for applications where labelled detection techniques could affect the characteristics of target molecules. Label-free array techniques offer a number of benefits in comparison to conventional labelled technique, including quick delivery, reliability, dependability, and accurate real-time results. This, along with low cost of label-free array technique, as no radioactive or fluorescent labels, dye, tags, or specialized reagents are needed for the preparation of assay makes them sought-after, says a recent label-free array systems market forecast. The label-free array systems market is estimated to clip a CAGR of 6.4% during the forecast period from 2022 to 2031.

Growth in demand for atomic force microscopy (AFM) is related its extensive applications, including diagnosis and conduct of cancer research. Ability of AFM to perform critical procedures on cells, under conditions that are close to physiological conditions, helps to study the mechanical properties of live cells. The potential of AFM to be used as a high-resolution research tool, to study mechanical characteristics and ultrastructure of tumor cells, enriches market demand for label-free array systems market.

Get Exclusive PDF Sample Copy of Label-free Array Systems Market Report –

Label-free Array Systems Market – Key Findings of the Report

  • Surface plasmon resonance (SPR) technology is gaining popularity as an optical detection technique for biosensors. Key players in the label-free array system market are geared toward understanding and acceptance, for increased use of SPR in clinical chemistry and medicine.
  • Microcantilevers is a leading segment based on technique, in the label-free array systems market. Demand for microcantilevers stems from their use to measure a range of physical, chemical, and biochemical variables. Furthermore, microcantilever array detection is characteristic of increased accuracy through the use of several sensors that are used concurrently. This paves way for applications in clinical, military, industrial, and consumer markets.
  • Drug discovery application segment held key share of label-free array systems market in 2021. Rising adoption of label-free techniques in drug discovery, elevated R&D costs, and rising demand for new and targeted drugs in pharmaceutical and life sciences industries are fueling the growth of drug discovery segment. Increase in government funding for label-free array system research, and rising applications of label-free techniques are spelling the growth of drug discovery application segment
  • Pharmaceutical & biotechnology industries end user segment is anticipated to rise at a rapid pace in the upcoming years. Increase in R&D investments by biotech and pharmaceutical companies is the key factor driving the segment.
  • North America held key share of label-free array systems market in 2021. The region is expected to lead the label-free array systems market during the forecast period. Increasing use in drug discovery programs in the U.S., due to the rising incidence of chronic and life-threatening diseases is propelling the label-free array system in the region.

Ask for References –

Label-free Array Systems Market – Growth Drivers

  • Popularity of label-free array systems as primary research tools, in different drug discovery processes propels label-free array systems market
  • Key advantages of label-free microarray methods to understand disease signaling pathway, drug target identification, biomarker screening, protein profiling and drug discovery catalyzes label-free array systems market

Label-free Array Systems Market – Key Players

Some of the key players operating in the label-free array systems market are;

  • GE Healthcare
  • Attana AB
  • Danaher Corporation
  • Bio-Rad Laboratories
  • PerlinElmer Inc.
  • Attana AB
  • F. Hoffmann- La Roche AG
  • GWC Technologies
  • BiOptix Inc.

Make an Enquiry Before Buying

The label-free array systems market is segmented as follows;

Label-free Array Systems Market, by Technique

  • Surface Plasmon Resonance
  • Microcantilever
  • Scanning Kelvin Nanoprobe
  • Enthalpy Array
  • Atomic Force Microscopy
  • Electrochemical Impedance Spectroscopy
  • Interference-based Technique
  • Ellipsometry Technique
  • Others

Label-free Array Systems Market, by Application

  • Drug Discovery
  • Biomolecular Interactions
  • Detection of Disease Biomarkers
  • Others

Label-free Array Systems Market, by End User

  • Contract Research Organization
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Industries
  • Others

Label-free Array Systems Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Anti-aging Market: The global anti-aging market for anti-wrinkle products was valued at US$ 8,400.0 Mn in 2018 and is projected to expand at a CAGR of 6.0% from 2019 to 2027.

Red Biotechnology Market: The global red biotechnology market is anticipated to reach more than US$ 609.6 Bn by the end of 2031.

Equine Supplement Products Market: The global equine supplement products market is anticipated to reach US$ 111 Mn by the end of 2031. The global market is projected to grow at a CAGR of 3.7% from 2022 to 2031

Skincare Serum Market: The global skincare serum market is anticipated to reach more than US$ 6.28 Bn by the end of 2031 with a CAGR of 7.4% from 2022 to 2031.

Epilepsy Therapeutics Market: The global epilepsy therapeutics market is anticipated to reach more than US$ 14.9 Bn by the end of 2031.

Smart Insulin Pens Market: The global smart insulin pens market size is prognosticated to expand at notable pace and reach a value of US$ 90.1 Mn by the end of 2031

Vitamin D Testing Market: The global vitamin D testing market is anticipated to reach more than US$ 1.06 Bn by the end of 2031 with a CAGR of 5.8 % from 2022 to 2031

Laboratory Gas Generators Market: The global laboratory gas generators market is anticipated to reach more than US$ 1.27 Bn by the end of 2031 with a CAGR of 11.0% from 2022 to 2031

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update -


Rohit Bhisey
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453